Your session is about to expire
← Back to Search
Standard vs. Telemedicine Surveillance for Head and Neck Cancer
Study Summary
This trial will compare standard surveillance with telemedicine surveillance for people with HPV-associated head and neck cancer. Quality of life, health outcomes, and expenses will be compared to determine which approach is better.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is enrollment still being accepted for this investigation?
"Affirmative. Clinicaltrials.gov reveals that recruitment for this medical experiment, which was first published on September 1st 2021, is still ongoing. The trial requires 160 participants and they must be located at a single clinical site."
How many subjects are currently receiving the experimental treatment in this trial?
"Indeed, according to the clinicaltrials.gov website, this investigation is still recruiting candidates. The trial was published on September 1st 2021 and its records were last updated on August 17th 2022. A total of 160 individuals are needed at a single site for the study's completion."
Share this study with friends
Copy Link
Messenger